Facultad de Ciencias de la Salud

1996

1. Ausencia de infección por VIH-2 en marineros Vascos que frecuentan la costa africana occidental.

   Anales de medicina interna (Madrid, Spain : 1984)

2. Circulating HIV-1 serotypes in Spain.

   Vox sanguinis

3. Correlation between serological and genetic methods for typing hepatitis C virus.

   Vox sanguinis

4. Detection of herpesvirus type 8 (HHV-8) sequences in patients with Kaposi's sarcoma in Spain

   JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY

5. First case of HIV-1 group O infection in Spain.

   Vox sanguinis

6. Hepatitis C viraemia in HIV-infected patients [3]

   AIDS

7. Hepatitis C virus genotypes in different risk populations in Spain [4]

   Journal of Infectious Diseases

8. High alcohol intake and slow progression to AIDS

   GENITOURINARY MEDICINE

9. High alcohol intake and slow progression to AIDS

   Sexually Transmitted Infections

10. High rate of indeterminate reactivity to HTLV in Western blot analysis of Spanish blood donors [4]

    Vox Sanguinis

11. High-dose, continuous r-TPA infusion for treatment of VOD [2]

    Bone Marrow Transplantation

12. INFECCION POR HTLV-1 EN DROGADICTOS ESPANOLES [2]

    Revista Clinica Espanola

13. Impact of antiretroviral therapy on hepatitis C viraemia in HIV-infected patients.

    Antiviral therapy

14. Importancia clínica de la variabilidad genética del virus de la inmunodeficiencia humana.

    Medicina clínica

15. Interferon-alpha for chronic hepatitis C in HIV-infected persons

    International Antiviral News

16. Lack of evidence for viral clearance in children born to HIV-infected mothers [8]

    AIDS

17. Long-term zidovudine responders: Is there still rationale for HIV monotherapy? [4]

    AIDS

18. Prevalence of zidovudine-resistant HIV-1 among rapid progressors [2]

    AIDS

19. Pulsed high-dose dexamethasone in the treatment of refractory immune thrombocytopenia [2]

    British Journal of Haematology

20. Rationale for early antiretroviral therapy in patients with CD4 cell counts > 500 cells/mm3.

    Antiviral therapy